US-based Medable has unveiled a telemedicine solution, called as Trial-Fit Telemedicine, only for clinical trials.

The solution has been developed and designed to address critical trial barriers of low patient retention and lack of access.

The Trial-Fit Telemedicine allows sites all over the world to carry out secure, HIPAA-compliant video consultations with clinical study participants in an integrated eCOA solution.

Medable co-founder and CEO Dr. Michelle Longmire said: “Medable is on a mission to get effective therapies to patients faster. Medable is building a globally connected research ecosystem in which every person in the world has the opportunity to benefit from cutting edge research. Telemedicine is an essential enabling technology in our mission to serve patients all over the world.”

The solution is claimed to be an integrated, multi-language and globally supported site and patient telemedicine experience that allow clinicians to remotely care for, monitor and manage study participants in any location.

Dr. Longmire continued: “Increasing access to trials is a top priority for Medable. 50% of trials do not achieve planned enrollment strategies… we are working to fix that.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The firm’s eClinical platform allows data-driven digital trials by making use of big data and analytics to identify patients and link them with trials powered by Medable eCOA solutions.

Medable’s telemedicine solution enables life science, biotech and medical device companies to expand a study’s geographic reach for patient enrollment.

Dr. Longmire added: “Digital technologies have the ability to revolutionize trials. Telemedicine can improve access, enrollment, and retention and is central to our strategy to reduce trial time, improve trial diversity, and enable an era of personalized medicine, which will require much broader study access and participation. Telemedicine is an important part of our strategy to make trials more representative and to radically reduce the time and cost, with the goal of getting effective therapies to patients faster.”

Medable will launch this new telemedicine at this year’s Drug Information Association (DIA) global annual meeting to be held in San Diego from 23-27 June.